Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Studio Pictures Ltd is a UK-based film and TV production company founded by producers Adam Rolston and David Braithwaite in 2019. Specializing in creating high-quality British entertainment content, the company focuses on adapting books to screen and telling unique true-life stories that entertain and inspire both domestic and international audiences. With successful productions like "A Street Cat Named Bob," the company is building a strong brand and reputation in the industry. Studio Pictures has access to top creative talent and collaborates with major studios like Warner Bros, Sony Pictures, Lionsgate, and Studio Canal. The company is located at Twickenham Studios in Richmond, UK.
days to go:
13
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Created in 2015, Fourex provides an advanced and innovative self-service kiosk for exchanging over 150 currencies in both coins and notes. The company has grown its revenue by 175 % and it is continuing to grow. It will be live in 80 locations by the end of 2019. Fourex has a presence at Heathrow, Gatwick, and Stansted with access to 153 million passengers per year. It is located in 21 London underground stations with a combined 1.9 million passengers each day. In early 2018, Fourex has extended its business from 12 locations to 66 locations. It has won innovation awards from Lloyds Bank, Virgin, and Amazon. The company's revenue has increased by 175% in 2 years. Fourex's current partners are TfL/London, Westfield, Underground, Welcome Break, Intu, Moto and Roadchef. The company aims to become a principal multi-currency exchange solution. With the proceeds, the company will be accelerating its growth in the UK, by expanding the network of machines nationwide both in international travel hubs, high footfall retails and transit locations.
days to go:
Expired
investment:
£928,830
B-North is a UK-based business lending company. It has combined cloud-native technology with face-to-face relationship banking. The company asserts that SMEs account for over 60% of private-sector employment in the UK, have driven job growth over the past ten years, and are central to driving economic recovery. It intends to disrupt the £150 billion UK Small and Medium Enterprise (SME) lending market. B-North has raised a seed capital of over £6.8 million including a six-figure investment from the Greater Manchester Combined Authority to establish its core team, as well as, build lending and deposit-taking platforms. The company is now seeking further investment through a bridge round to extend the cash runway from the end of Q4 2020 into Q1-Q2 2021 to achieve the necessary regulatory capital to become a bank and commence lending.
days to go:
Expired
investment:
£2,149,256
DNApal is a personalised diet, health and fitness app that combines DNA infomation with other factors like age, weight, diet, family history and health goals. Two of the largest consumer DNA companies, 23andMe and Ancestry.com, have tested over 18m people. DNApal is capable of interpreting DNA results from these companies to provide precise recommendations on how to improve diet, hormone balance, weight loss, sleep, fitness & more. The company also won the best pitch at VentureFest 2019 at Oxford Brookes University. DNApal is aiming to launch MVP in January 2020 (iOS). The company is also aiming to recommend further testing and specific supplements where necessary and offer 1:1 consultations with a specialist. With the fund raised, DNApal plans to develop the full scope of the app, weekly goals, content challenges to keep users committed.
days to go:
Expired
investment:
£49,990
DMALINK aims to create a transparent and accessible currency market for banks, funds, and corporations. The company asserts that the Foreign Exchange (FX) market is the world's largest and most liquid financial market, recording an average daily trading volume of $6.6 Trillion but is fraught with imperfect price movements. DMALINK aims to address this situation. Its portal utilises big data and analytics solutions to enable users to make better trading decisions. It also offers users access to 63 currency pair combinations. DMALINK also points out that its clients have chosen its services over 316,000 times with the company witnessing an average deal size of $585,000 and earning revenue worth $3,140,000. The company has featured in Business Insider, Yahoo Finance, and FX Markets to name a few. DMALINK will use 60% of the investment on salaries for existing and new team members allowing global growth, 20% towards marketing and sales efforts, and 20% towards technology expansion.
days to go:
Expired
investment:
£425,903
The go-to platform for people planning the most important purchase of their lives: a new home.
days to go:
Expired
investment:
£103,008
